Does TECLISTAMAB-CQYV Cause Infection? 83 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Infection have been filed in association with TECLISTAMAB-CQYV. This represents 5.2% of all adverse event reports for TECLISTAMAB-CQYV.
83
Reports of Infection with TECLISTAMAB-CQYV
5.2%
of all TECLISTAMAB-CQYV reports
31
Deaths
28
Hospitalizations
How Dangerous Is Infection From TECLISTAMAB-CQYV?
Of the 83 reports, 31 (37.3%) resulted in death, 28 (33.7%) required hospitalization, and 3 (3.6%) were considered life-threatening.
Is Infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
Pneumonia (58)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which TECLISTAMAB-CQYV Alternatives Have Lower Infection Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL